India’s OTC Pharma Market Projected to Reach ₹98,000 Crore by 2030: EY
India’s over-the-counter (OTC) pharmaceutical market is expected to grow to ₹98,000 crore by 2030, driven by rising self-medication trends, expanding […]
News
India–EU FTA Opens $572 Billion Pharma, MedTech Market for Indian Companies
The India–European Union Free Trade Agreement (FTA) is set to provide Indian pharmaceutical and medical technology companies access to a […]
Novo Medi Sciences Launches Next-Generation Varicella Vaccine NEXIPOX PLUS®
Novo Medi Sciences Pvt. Ltd. has announced the launch of NEXIPOX PLUS®, a next-generation varicella (chickenpox) vaccine, developed using an […]
Naprod Life Sciences Secures ANVISA GMP Renewal for Tarapur Facility
Naprod Life Sciences has secured the renewal of its ANVISA Good Manufacturing Practice (GMP) certification for its manufacturing facility located […]
Sarepta’s Duchenne Gene Therapy Shows Sustained Benefit at Three Years
Sarepta Therapeutics has reported three-year data showing slowed disease progression for its gene therapy Elevidys in patients with Duchenne muscular […]
API Makers Seek Import Curbs, GMP Upgrade Support in Budget 2026
India’s active pharmaceutical ingredient (API) manufacturers have urged the government to introduce import curbs and support for GMP upgrades in […]
Janux Therapeutics, Bristol Myers Squibb Enter Up to $850 Million Cancer Drug Deal
Janux Therapeutics has entered into a collaboration and licensing agreement with Bristol Myers Squibb (BMS) valued at up to USD […]
GSK Acquires Rapt Therapeutics in $2.2 Billion Deal for Food Allergy Drug
GSK has agreed to acquire Rapt Therapeutics in a transaction valued at approximately USD 2.2 billion, securing rights to the […]
Qure.ai Secures Gates Foundation Grant to Develop AI-Powered Point-of-Care Ultrasound
Qure.ai has received a multimillion-dollar global health grant from the Gates Foundation to develop AI-powered point-of-care ultrasound solutions aimed at […]
Novavax Licenses Matrix-M Vaccine Technology to Pfizer in Strategic Development Deal
Novavax has entered into a licensing agreement with Pfizer that allows the global pharmaceutical major to use Novavax’s Matrix-M adjuvant […]
Rainbow Children’s Medicare Appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children’s Medicare Limited has appointed Abrarali Dalal as its Chief Executive Officer, effective January 20, 2026, as part of […]
Narayana Hrudayalaya Incorporates Wholly Owned Subsidiary for North India Operations
Narayana Hrudayalaya Limited has incorporated a wholly owned subsidiary, Narayana Healthcare North Private Limited, to strengthen its healthcare operations in […]
Novo Nordisk Expands Cell Therapy Partnership with Aspect Biosystems for Diabetes
Novo Nordisk has expanded its collaboration with Aspect Biosystems to accelerate the development of cell-based therapies for diabetes, strengthening a […]
